Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Antibiot Khimioter ; 37(7): 19-25, 1992 Jul.
Artículo en Ruso | MEDLINE | ID: mdl-1456803

RESUMEN

The experimental study of recombinant human insulin revealed its high specific activity. The kinetics of the hypoglycemic effect of various dosage forms of the insulin developed at the National Research Centre of Antibiotics and the dosage forms manufactured by Eli Lilly was similar. The pharmacological investigation of the dosage forms showed that they had no side effects on the vitally important organs and systems. It was concluded that the dosage forms of the gene engineered human insulin developed at the National Research Centre of Antibiotics did not differ by their characteristics from the analogous dosage forms manufactured in other countries.


Asunto(s)
Modelos Animales de Enfermedad , Hiperglucemia/tratamiento farmacológico , Insulina/uso terapéutico , Animales , Glucemia/análisis , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Tolerancia a Medicamentos , Cobayas , Hiperglucemia/sangre , Inyecciones Subcutáneas , Insulina/administración & dosificación , Insulina/genética , Ratones , Conejos , Ratas , Recombinación Genética , Especificidad de la Especie
2.
Antibiot Khimioter ; 37(3): 18-20, 1992 Mar.
Artículo en Ruso | MEDLINE | ID: mdl-1514861

RESUMEN

The action of clindamycin monohydrate on the general state and weight rise, liver and kidney functions, peripheral blood count and pathomorphological state of the viscera was studied on rats in chronic experiments. Clindamycin was administered to laboratory animals orally in doses of 50, 100, 150 and 300 mg/kg. It was shown that some adverse reactions to the drug and in particular disorders in blood coagulation and morphological changes in the intestine did not depend on its dose and were due to duration of the drug use and probable development of dysbacteriosis. At the same time the disorders in the liver and kidney functions though transitory did depend, to a greater extent, on the dose and were evident after the antibiotic overdosage.


Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Clindamicina/toxicidad , Intestino Delgado/efectos de los fármacos , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Modelos Biológicos , Administración Oral , Animales , Clindamicina/administración & dosificación , Relación Dosis-Respuesta a Droga , Riñón/patología , Hígado/patología , Tamaño de los Órganos/efectos de los fármacos , Ratas , Factores de Tiempo
3.
Antibiot Khimioter ; 37(2): 25-8, 1992 Feb.
Artículo en Ruso | MEDLINE | ID: mdl-1514850

RESUMEN

The effect of sulacillin, a combination of sulbactam and ampicillin (1:2), on the functions of the liver and kidneys, peripheral blood count, cardiovascular and central nervous systems was studied in acute and chronic experiments on animals of various species. The allergenic and local irritating properties of the combination were also studied. It was shown that the combination was low toxic and the interaction of sulbactam and ampicillin by the lethal effect was additive. When the combination was administered intravenously to mice, its LD50 amounted to 6 g/kg. In chronic experiments on rats parenterally given the combination in doses equivalent to the therapeutic ones there were no changes in the examined systems and organs. When used in the doses exceeding the therapeutic ones, sulacillin used during long periods induced a transitory elevation of blood levels of transaminases and alkaline phosphatases, an increase in the relative weight of the liver and kidneys, elongation the typhlon and an increase in glycogen levels in the hepatocytes without morphological changes. The combination had no significant effect of sulacillin and the painful injections alleviated by local anesthesia were recorded. The allergenic properties of the combination were moderate and did not differ from those of ampicillin. The data indicate that the combined sulacillin preparation greatly resembles its foreign analogue.


Asunto(s)
Ampicilina/toxicidad , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Modelos Biológicos , Sulbactam/toxicidad , Ampicilina/administración & dosificación , Animales , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Sinergismo Farmacológico , Inyecciones Intramusculares , Inyecciones Intravenosas , Riñón/patología , Hígado/patología , Ratones , Tamaño de los Órganos/efectos de los fármacos , Ratas , Especificidad de la Especie , Sulbactam/administración & dosificación
4.
Antibiot Khimioter ; 37(1): 32-5, 1992 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-1530356

RESUMEN

Biopolyene is a mixture of ethyl ethers of polyunsaturated fatty acids isolated from biomass of Entomophthora virulenta, a mycelial fungus. Its acute and chronic toxicity was studied on rats and guinea pigs. After oral administration of the preparation in single doses exceeding 50 g/kg there were no disorders in the general state of the rats. In chronic experiments with oral biopolyene in doses of 100 and 500 mg/kg and its local application to the intact skin of the animals in a dose of 1 g/kg there were no significant changes in the functional state of the liver and kidneys as well as the peripheral blood count. Insignificant changes in the serum levels of liver enzymes and coagulation were transient. The preparation showed no allergenic or immunomodulating effects. It had neither embryotoxic, teratogenic nor mutagenic action.


Asunto(s)
Entomophthora/metabolismo , Éteres de Etila/farmacología , Ácidos Grasos Insaturados/biosíntesis , Ácidos Grasos Insaturados/farmacología , Cicatrización de Heridas/efectos de los fármacos , Administración Cutánea , Administración Oral , Animales , Recuento de Células Sanguíneas/efectos de los fármacos , Tolerancia a Medicamentos/fisiología , Éteres de Etila/administración & dosificación , Éteres de Etila/uso terapéutico , Ácidos Grasos Insaturados/administración & dosificación , Ácidos Grasos Insaturados/uso terapéutico , Femenino , Cobayas , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Ratas
5.
Antibiot Khimioter ; 35(9): 26-7, 1990 Sep.
Artículo en Ruso | MEDLINE | ID: mdl-2275586

RESUMEN

Gentacycol is a local dosage form of gentamicin based on collagen for implantation to wounds in treatment of patients with infections of soft tissues and prevention of contamination of open injuries of the bones and soft tissues. General toxic and organotropic properties of gentacycol were studied on animals with subcutaneous implantation of the dosage form in doses equivalent to the therapeutic dose for man and exceeding it 2-fold. The study showed that the dosage form had no unfavourable side effects on the animal general state, hearing, the functional state of the liver and kidneys and the peripheral blood. In the doses tested gentacycol did not influence the indices of the cardiovascular system and neuromuscular conduction. Morphological examination of the skin and hypodermic tissues in the implantation site revealed no damaging action of the dosage form on the surrounding tissues.


Asunto(s)
Gentamicinas/administración & dosificación , Animales , Colágeno , Implantes de Medicamentos , Gentamicinas/toxicidad , Cobayas , Dosificación Letal Mediana , Concentración Máxima Admisible , Ratas
6.
Antibiot Khimioter ; 35(9): 28-9, 1990 Sep.
Artículo en Ruso | MEDLINE | ID: mdl-2275587

RESUMEN

A novel formulation for local application based on an enzyme of microbial origin, C protease, and two antibiotics, gentamicin and erythromycin, was studied on various experimental models in rats with respect to its effect on necrotic tissues and recovery of the skin and hypodermic tissue defects due to wounds. It was found that even within the first days of the application the formulation induced lysis of the primary crust, lowered exudation and promoted debridement, reduced the wound size and completely closed it. By its effect the formulation was similar to iruxol. In chronic experiments on animals with long-term application of the formulation to the skin and wound surfaces it showed no unfavourable general toxic or organotropic properties. The local irritating action was insignificant.


Asunto(s)
Eritromicina/administración & dosificación , Gentamicinas/administración & dosificación , Péptido Hidrolasas/administración & dosificación , Administración Cutánea , Animales , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada/administración & dosificación , Quimioterapia Combinada/toxicidad , Eritromicina/toxicidad , Gentamicinas/toxicidad , Cobayas , Pomadas , Péptido Hidrolasas/toxicidad , Ratas , Serina Endopeptidasas , Cicatrización de Heridas/efectos de los fármacos
7.
Antibiot Khimioter ; 35(5): 25-7, 1990 May.
Artículo en Ruso | MEDLINE | ID: mdl-2383151

RESUMEN

The action of cefotaxime on the functions of the liver and kidneys, the peripheral blood count, growth and development of young animals, blood circulation, respiration and the central nervous system was studied in acute and chronic experiments on mice and rats. Allergenic, immunomodulating, embryotoxic and teratogenic properties of the antibiotic were also studied. Cefotaxime was shown to be low toxic. After intravenous administration to mice, its LD50 amounted to 7000 (6295-7805) mg/kg. In the chronic experiments on rats with intramuscular and intravenous administration of the antibiotic in doses equivalent by the body surface to the course doses for humans there were no significant shifts in the function of the liver and kidneys, the count of the blood formed elements and the histologic pattern of the viscera. In the therapeutic doses the antibiotic had no action on hemopoiesis, respiration and the central nervous system. The allergenic properties of cefotaxime were slightly pronounced and similar to those of klaforan. The antibiotic had no action on the host immunity and showed no embryotoxic and teratogenic properties. After intravenous and intramuscular administration, cefotaxime had a slight irritating action on the tissues which was similar to that of klaforan.


Asunto(s)
Cefotaxima/toxicidad , Animales , Recuento de Células Sanguíneas , Circulación Sanguínea/efectos de los fármacos , Cefotaxima/análogos & derivados , Sistema Nervioso Central/efectos de los fármacos , Pruebas Enzimáticas Clínicas , Embrión de Mamíferos/efectos de los fármacos , Femenino , Crecimiento/efectos de los fármacos , Riñón/efectos de los fármacos , Dosificación Letal Mediana , Hígado/efectos de los fármacos , Ratones , Embarazo , Ratas , Respiración/efectos de los fármacos , Factores de Tiempo
9.
Antibiot Med Biotekhnol ; 32(6): 453-60, 1987 Jun.
Artículo en Ruso | MEDLINE | ID: mdl-3631939

RESUMEN

The general toxic and organotropic properties of azlocillin were studied in acute and chronic experiments with various animal species. By the body surface area the doses of azlocillin were equivalent to the drug average and maximum course doses for humans. The aim of the study was to determine the drug dose inducing certain side effects. It was found that only in a dose equivalent to the maximum course dose for humans i. e. 300 g the drug induced a transient increase in the blood levels of aspartate aminotransferase and alkaline phosphatase and some increase in the coagulation time. The allergenic properties of the drug were slightly pronounced. Within the tested doses azlocillin did not affect the peripheral blood indices and showed no immunomodulating embryotoxic, teratogenic or mutagenic effect. The experimental data indicated that the range between the drug therapeutic course doses and the doses inducing certain side effects was significant. This is evidence of a sufficiently high level of azlocillin safety.


Asunto(s)
Azlocilina/toxicidad , Adyuvantes Inmunológicos , Animales , Sangre/efectos de los fármacos , Sistema Cardiovascular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Embrión de Mamíferos/efectos de los fármacos , Riñón/efectos de los fármacos , Dosificación Letal Mediana , Hígado/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Mutágenos , Nervios Periféricos/efectos de los fármacos , Ratas , Respiración/efectos de los fármacos , Factores de Tiempo
10.
Artículo en Ruso | MEDLINE | ID: mdl-2954348

RESUMEN

Experiments were conducted on animals to study intrathecal injection of agents differing in the mechanism of action: variamycin, mitramycin, reumycin, proxyphein, and prospidin. Their acute toxicity in a single intracerebral injection and chronic toxicity in repeated suboccipital injection were studied. The brains of animals who died or were killed were studied pathomorphologically in different periods. Intracerebrally and suboccipitally injected variamycin and mitramycin induced marked toxic reactions, even the death of animals, and cannot be recommended for the neurooncological clinic. The antineoplastic reumycin, proxyphein, and prospidin cause no toxic reactions of the brain and meninges on injection by the above mentioned methods; they are recommended for approbation in the neurooncological clinic for the treatment of patients with malignant tumors of the brain by injection into the system of the cerebrospinal fluid.


Asunto(s)
Antineoplásicos/toxicidad , Encefalitis/inducido químicamente , Animales , Antineoplásicos/administración & dosificación , Dextropropoxifeno/toxicidad , Perros , Ratones , Plicamicina/análogos & derivados , Plicamicina/toxicidad , Prospidio/toxicidad , Conejos , Ratas , Triazinas/toxicidad
11.
Antibiot Med Biotekhnol ; 31(10): 785-90, 1986 Oct.
Artículo en Ruso | MEDLINE | ID: mdl-3789689

RESUMEN

The action of cefazolin on the pharmacokinetics and nephrotoxic effect of sisomicin was studied on Wistar rats. Sisomicin in doses of 12.5 and 25 mg/kg alone or in combination with cefazolin in doses of 90 and 360 mg/kg was administered intramuscularly to the animals daily for 16 days. It was shown that in both the doses cefazolin had no noticeable action on the level of the functional and morphological changes in the kidneys. Consequently, there were no significant changes in the levels of sisomicin in serum and the site of the nephrotoxic effect (cortical layer of the kidneys) and in the half-life of the aminoglycoside in the kidney cortical layer under the action of cefazolin. At the same time there was observed a marked individual variability of the levels of urea nitrogen and sisomicin in serum of the rats treated with the aminoglycoside alone or in combination with cefazolin. Analysis of the dependence of the nephrotoxic effect on concentration of sisomicin in serum after its use alone or in combination with cefazolin revealed that the changes in the individual intensity of the effect in all the cases were mainly induced by the changes in the sisomicin blood levels. Therefore, control of the blood levels of the aminoglycoside should provide prevention of the development of its nephrotoxic effect not only in monotherapy but also in the use of aminoglycosides in combination with cefazolin.


Asunto(s)
Cefazolina/farmacología , Riñón/efectos de los fármacos , Sisomicina/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Femenino , Riñón/metabolismo , Cinética , Masculino , Ratas , Ratas Endogámicas , Sisomicina/toxicidad , Factores de Tiempo
12.
Antibiot Med Biotekhnol ; 30(12): 918-27, 1985 Dec.
Artículo en Ruso | MEDLINE | ID: mdl-3866512

RESUMEN

Aclarubicin (ACR) has a selective inhibitory effect on the synthesis of RNA in the cells. The time of the antibiotic contact with the cells is an important factor in realization of its cytotoxic activity. As compared to adriamycin, ACR has a low specific activity in lymphoid leukemia P388, melanoma B16 and lung cancer LL. The therapeutic efficacy of ACR depended on the scheme of its use: in treatment of rapidly proliferating tumors such as P388 the highest effect is attained with the daily use of the antibiotic for 9 days, in treatment of slowly developing melanoma B16 the results were more satisfactory with intermittent use of the drug on days 1, 5 and 9 after the strain transplantation. The new antibiotic was highly effective on its use either intravenously or orally.


Asunto(s)
Antibióticos Antineoplásicos/uso terapéutico , Aclarubicina , Animales , Antibióticos Antineoplásicos/administración & dosificación , Antibióticos Antineoplásicos/toxicidad , Células Cultivadas , ADN de Neoplasias/biosíntesis , Doxorrubicina/uso terapéutico , Evaluación Preclínica de Medicamentos , Femenino , Técnicas In Vitro , Dosificación Letal Mediana , Leucemia P388/tratamiento farmacológico , Masculino , Ratones , Naftacenos/administración & dosificación , Naftacenos/uso terapéutico , Naftacenos/toxicidad , Trasplante de Neoplasias , Neoplasias Experimentales/tratamiento farmacológico , Factores de Tiempo
13.
Antibiot Med Biotekhnol ; 30(5): 355-60, 1985 May.
Artículo en Ruso | MEDLINE | ID: mdl-4026256

RESUMEN

The general toxic and organotropic properties of amikacin were studied in acute and chronic experiments. The antibiotic was administered to the experimental animals in the doses equivalent to the therapeutic ones for humans or exceeding them 2-3 times. No unfavourable effect of amikacin in the above doses on hearing was observed. A certain increase in the level of urea nitrogen in the blood serum and leukopenia were registered only after administration of the highest drug dose exceeding 2 times the equivalent treatment dose of amikacin for humans (15 g). After the use of this dose separate microfocal necrotic lesions were detected morphologically in the proximal tubules of the kidneys. The lesions were of a transitory nature. It is concluded that amikacin has a wide range of therapeutic doses and the level of its safety is rather high.


Asunto(s)
Amicacina/farmacología , Kanamicina/análogos & derivados , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Amicacina/toxicidad , Animales , Aspartato Aminotransferasas/sangre , Bilirrubina/sangre , Recuento de Células Sanguíneas , Nitrógeno de la Urea Sanguínea , Gatos , Granulocitos/efectos de los fármacos , Cobayas , Conejos , Ratas
14.
Antibiot Med Biotekhnol ; 30(3): 190-6, 1985 Mar.
Artículo en Ruso | MEDLINE | ID: mdl-4015061

RESUMEN

The effect of cephalothin on the nephrotoxicity and pharmacokinetics of sisomicin was studied on Wistar rats. Sisomicin was injected intramuscularly in doses of 12.5 and 25 mg/kg alone or in combination with cephalothin in a dose of 360 mg/kg once a day for 16 days. It was shown that the combined use of sisomicin and cephalothin resulted in less pronounced functional and morphological changes in the kidneys as compared to the use of sisomicin alone. The decrease in the nephrotoxic effect was accompanied by a decrease in the sisomicin concentration in the blood serum and the site of the nephrotoxic effect (the kidney cortical layer) and the period of the aminoglycoside half-life in the kidney cortical layer under the action of cephalothin. The analysis of the relation between the nephrotoxic effect and the concentration of sisomicin in the kidney cortical layer and blood serum demonstrates that the nephrotoxicity of the sisomicin combination with cephalothin is mainly due to a decrease in the aminoglycoside concentration in the zone of the nephrotoxic effect.


Asunto(s)
Cefalotina/farmacología , Necrosis de la Corteza Renal/inducido químicamente , Riñón/efectos de los fármacos , Sisomicina/toxicidad , Animales , Femenino , Semivida , Riñón/metabolismo , Corteza Renal/efectos de los fármacos , Corteza Renal/patología , Necrosis de la Corteza Renal/patología , Cinética , Masculino , Ratas , Ratas Endogámicas , Sisomicina/antagonistas & inhibidores , Sisomicina/metabolismo
15.
Antibiotiki ; 28(9): 678-82, 1983 Sep.
Artículo en Ruso | MEDLINE | ID: mdl-6605712

RESUMEN

General toxic and organotropic properties of sisomicin sulfate were studied in chronic experiments on different animal species with the use of doses equivalent to therapeutic ones in humans or exceeding them by several times. When sisomicin was injected intramuscularly for 4 weeks in a dose equivalent by the body surface to the average daily dose for humans, no significant effect on the macroorganism was observed. When the dose was 2--4 times higher, a significant increase in the blood serum levels of the urea nitrogen, creatinine, bilirubin and aspartate aminotransferase was shown. Histological examinations revealed focal adiposis of epithelial cells of the convoluted tubules of the kidney and small areas of parenchymal necrosis. Impairment of vestibular and auditory functions was detected in some animals.


Asunto(s)
Sisomicina/toxicidad , Animales , Células Sanguíneas/efectos de los fármacos , Gatos , Relación Dosis-Respuesta a Droga , Tolerancia a Medicamentos , Crecimiento/efectos de los fármacos , Cobayas , Inmunización , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Conejos , Ratas , Sisomicina/inmunología , Factores de Tiempo , Vestíbulo del Laberinto/efectos de los fármacos
16.
Antibiotiki ; 27(4): 287-92, 1982 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-7092200

RESUMEN

Nephrotoxicity and pharmacokinetics of gentamicin were studied on rats treated with the antibiotic for 30 days in doses of 6.25, 12.5 and 25 mg/kg administered daily. The pharmacokinetics of gentamicin and the time course of changes in the urea nitrogen levels of the blood serum were studied after the 1st, 5th, 8th and 30th injection. The analysis of the respective curves was used for calculation of the average integral values of the concentrations of the antibiotic (C) and urea nitrogen (E). After that the average integral values of these parameters ((CAVG and EAVG respectively) within the whole treatment couse with the use of every dose were calculated in the same way by using the curves of the dynamics of C and E changing. Comparison of the diagrams of E dependence on C for gentamicin and sisomycin showed that nephrotoxicity of sisomycin was 1.48 times higher than that of gentamicin.


Asunto(s)
Aminoglicósidos/toxicidad , Gentamicinas/toxicidad , Riñón/efectos de los fármacos , Animales , Nitrógeno de la Urea Sanguínea , Relación Dosis-Respuesta a Droga , Gentamicinas/administración & dosificación , Gentamicinas/sangre , Cinética , Métodos , Ratas , Ratas Endogámicas , Sisomicina/administración & dosificación , Sisomicina/sangre , Sisomicina/toxicidad , Factores de Tiempo
17.
Antibiotiki ; 26(4): 290-7, 1981 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-7235670

RESUMEN

The pharmacokinetics of tobramycin after its intravenous or intramuscular injection in a dose of 80 mg for 60 minutes was studied in 8 patients with chronic glomerulonephritis in the terminal stage of chronic renal insufficiency. The drug levels wee determined in the arterial (CA) and venous (CV) blood and dialyzates (CD) during the hemodialysis (6 hours) and 13-70 hours before the hemodialysis. The antibiotic was administered simultaneously with connection of the "artificial kidney" apparatus (KIIL) or 1 hour after it. The values of the clearance (CID) and dialyzing (D) of tobramycin were calculated with the following equations: (CID)1 equals Q(CA minus CV)/CA; (CID)4 equals FCD/CA; (D)2 equals Q(CA minus CV)/(CA minus CD); (D)5 equals FCD/(CA minus CD), where Q and F are the rates of the blood and dialysate flow respectively. In all cases the values of CID and D correlated and the difference between them was not significant. During the hemodialysis the values of (CID)1 varied to a greater extent than those of (CID)4. Irrespective of the procedure for estimation of CID the above variation was not pronounced, when tobramycin was administered simultaneously with initiation of the hemodialysis or during it than long before connection of the "artificial kidney" apparatus. In this connection it is recommended that antibiotic extraction be characterized by determination of (CID)4 on the drug administration long before the initiation of the hemodialysis. When Q equals 200 ml/min and F equals 600 ml/min, the average value of CLD for tobramycin was equal to 64 ml/min and the extraction coefficient was equal to 35 per cent.


Asunto(s)
Aminoglicósidos/aislamiento & purificación , Antibacterianos/aislamiento & purificación , Riñones Artificiales , Tobramicina/aislamiento & purificación , Adulto , Femenino , Glomerulonefritis/terapia , Humanos , Fallo Renal Crónico/terapia , Cinética , Masculino , Persona de Mediana Edad , Diálisis Renal , Factores de Tiempo , Tobramicina/metabolismo
18.
Antibiotiki ; 26(1): 50-5, 1981 Jan.
Artículo en Ruso | MEDLINE | ID: mdl-7212683

RESUMEN

The kinetics of the urea nitrogen in serum was studied on anesthetized cats with constant concentrations of sisomycin in the blood. A correlation between the nephrotoxic effect of sisomycin and its concentration in the blood serum was found. High nephrotoxicity of sisomycin as compared to that of gentamicin, kanamycin or streptomycin under conditions of their equal levels in the blood was revealed on the basis of the above correlation. Still, when the antibiotic concentrations in the blood serum were maintained at the respective therapeutic levels, the nephrotoxic effects of sisomycin and gentamicin were almost equal. The above correlation was used for calculation of the maximum value of the sisomycin safe concentration in blood serum. The safe concentration of gentamicin in blood serum is 8 micrograms/ml, while that of sisomycin in 6 micrograms/ml. This approach may be used in estimation of safe concentrations for new aminoglycosides.


Asunto(s)
Gentamicinas/sangre , Riñón/efectos de los fármacos , Sisomicina/sangre , Animales , Nitrógeno de la Urea Sanguínea , Gatos , Relación Dosis-Respuesta a Droga , Cinética , Matemática , Sisomicina/toxicidad , Factores de Tiempo
19.
Antibiotiki ; 25(7): 513-8, 1980 Jul.
Artículo en Ruso | MEDLINE | ID: mdl-7406463

RESUMEN

The effect of carfecillin on blood circulation, respiration, hepatic and renal functions, peripheral blood picture, growth and development of young animals was studied in acute and chronic experiments. The allergizating properties of the drug were also investigated. Carfecillin is low toxic. LD50 for albino mice on intravenous and oral administration of the drug is 782.5 and 3924 mg/kg respectively. When used repeatedly for treatment of rats in oral doses of 180 and 275 mg/kg corresponding to the daily doses for humans calculated for the body surface, carfecillin had no adverse effect on hepatic or renal function, cell composition of the blood, augmentation of the weight and relative weight of the organs of the growing animals. No detectable effect of carfecillin on arterial pressure, respiration, rhythm and amplitude of the systole was observed in acute experiments with anesthetized cats treated with the antibiotic intravenously in doses of 320 mg/kg. Histological examination of the internal organs of the rats treated with oral carfecillin during 2 months showed that the drug had an irritating effect on the gastrointestinal mucosa only in a dose of 540 mg/kg, which is 2 times higher than the equivalent daily dose for humans. Carfecillin possesses the allergizating properties and induces development of cross allergy to benzylpenicillin. The above properties were less pronounced in carfecillin than in benzylpenicillin.


Asunto(s)
Carbenicilina/análogos & derivados , Carfecilina/toxicidad , Animales , Sangre/efectos de los fármacos , Carfecilina/administración & dosificación , Carfecilina/inmunología , Relación Dosis-Respuesta a Droga , Femenino , Inmunización , Riñón/efectos de los fármacos , Dosificación Letal Mediana , Hígado/efectos de los fármacos , Masculino , Ratones , Conejos , Ratas , Factores de Tiempo
20.
Antibiotiki ; 25(4): 275-80, 1980 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-7369731

RESUMEN

The kinetics of urine nitrogen in the blood serum and morphological changes in the kidneys after a single and repeated intramuscular administrations of the antibiotic in doses of 12.5 and 25 mg/kg a day were studied in Wistar rats. When sisomycin was administered in a dose of 12.5 mg/kg, the increase in the urine nitrogen level after 1--30 injections was reversible, whereas at a dose of 25 mg/kg it became irreversible already after the 5th injection. Maximum deviations in the urine nitrogen level observed within 3--6 hours after each injection of sisomicin were recorded after the 5th injection of the drug in a dose of 12.5 mg/kg and even after the 1st injection of the drug in a dose of 25 mg/kg. The deviations increased up to the 5th and 16th injection of sisomycin in doses of 12.5 and 25 mg/kg respectively. Later the deviations were less pronounced. Regardless of the dose, adipose degeneration in renal tubules was registered after 8--16 injections of the drug. By the 30th and 16th days of the drug administration in doses of 12.5 and 25 mg/kg respectively, the above changes also decreased. On the whole, pronounced functional and morphological changes in the kidneys correlated with the antibiotic dose. Relationship between the time from the beginning of sisomycin administration and the moment when the average integral concentration of the urine nitrogen increased to the upper limit of normal and the logarithm of the average integral concentration of the antibiotic in the serum was found. The safety of the clinical schemes for the use of sisomicin was estimated with the help of this relationship with respect to its nephrotoxic effect.


Asunto(s)
Gentamicinas/toxicidad , Riñón/efectos de los fármacos , Sisomicina/toxicidad , Animales , Nitrógeno de la Urea Sanguínea , Relación Dosis-Respuesta a Droga , Riñón/patología , Cinética , Ratas , Sisomicina/sangre , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA